Evidence map›Paper›PMID 33732385›Full record

ReviewOncology letters2021

Deciphering the structure, function, expression and regulation of aquaporin-5 in cancer evolution.

Liping Wang, Da Huo, Haiyan Zhu, Qian Xu, Chengpeng Gao, Wenfeng Chen, Yixiang Zhang

Open access · diamondAbstract readReview
In one paragraph

Review in Oncology letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Aquaporin 5 expression regulates MDA-MB-231 spheroid multicellular invasion.American journal of physiology. Cell physiology · 2025
    Article
  4. Article
  5. Review
  6. Aquaporin-5 Dynamic Regulation.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Liping WangDepartment of Oncology, Weifang People's Hospital, Weifang, Shandong 261000, P.R. China.
Da HuoDepartment of Oncology, Weifang People's Hospital, Weifang, Shandong 261000, P.R. China.
Haiyan ZhuDepartment of Oncology, Weifang People's Hospital, Weifang, Shandong 261000, P.R. China.
Qian XuDepartment of Oncology, Weifang People's Hospital, Weifang, Shandong 261000, P.R. China.
Chengpeng GaoDepartment of Respiratory, Weifang People's Hospital, Weifang, Shandong 261000, P.R. China.
Wenfeng ChenDepartment of Science and Education, Weifang People's Hospital, Weifang, Shandong 261000, P.R. China.
Yixiang ZhangDepartment of Respiratory, Weifang People's Hospital, Weifang, Shandong 261000, P.R. China.
Weifang People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, the morbidity rate resulting from numerous types of malignant tumor has increased annually, and the treatment of tumors has been attracting an increasing amount of attention. A number of recent studies have revealed that the water channel protein aquaporin-5 (AQP5) has become a major player in multiple types of cancer. AQP5 is abnormally expressed in a variety of tumor tissues or cells and has multiple effects on certain biological functions of tumors, such as regulating the proliferation, apoptosis and migration of tumor cells. It has been suggested that AQP5 may play an important role in the process of tumor development, opening up a new field of tumor research. The present review highlighted the structure of AQP5 and its role in tumor progression. Furthermore, the expression of AQP5 in different malignant neoplasms was summarized. In addition, the influence of not only drugs, but also different compounds on AQP5 were summarized. In conclusion, according to the findings in the present review, AQP5 has potential as a novel therapeutic target in human cancer, and other AQPs should be similarly investigated.

Indexed as

aquaporin-5cancercancer therapydrugsdrug target

Identifiers

PMID33732385
PMCPMC7905525
OpenAlexW3130538018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.